Home › Trial NCT05519384
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
- Trial IDNCT05519384
- StatusUnknown
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorInstitute of Hematology & Blood Diseases Hospital, China
- Enrollment12
- Start date2022-09-14
- ConditionsAcute Myeloid Leukemia, Childhood · Relapsed Leukemia · Refractory Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.